Home › Funds › Tieton Capital Management, LLC › NAGE

Tieton Capital Management, LLC position in NAGE

NIAGEN BIOSCIENCE INC · Health Care

Tieton Capital Management, LLC reported holding 2,468,978 shares of NAGE (NIAGEN BIOSCIENCE INC) in its Q3 2026 13F filing — a position valued at US$7.2M, representing 2.15% of its reported portfolio and ranking #24 among its reported holdings. Tieton Capital Management, LLC has disclosed NAGE holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)2.47M sh
Reported value held$7.21M
Portfolio Weight2.15%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Tieton Capital Management, LLC's NAGE position evolved

Tieton Capital Management, LLC first disclosed a stake in NAGE in Q3 2023 at 2,451,983 shares (US$3.6M). The position peaked in Q2 2025 at 1,581,310 shares, worth US$22.8M. Across 13 filings, Tieton Capital Management, LLC increased the stake 5 time(s), trimmed it 5 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 2,468,978 shares valued at US$7.2M — an increase of 460,508 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.45M $3.58M New
Q4 2023 2.91M $4.17M Add
Q1 2024 3.02M $10.52M Add
Q2 2024 2.97M $8.10M Reduce
Q3 2024 2.96M $10.79M Hold
Q4 2024 2.59M $13.73M Reduce
Q1 2025 1.99M $13.70M Reduce
Q2 2025 1.58M $22.79M Reduce
Q3 2025 1.65M $15.37M Add
Q4 2025 1.65M $10.46M Hold
Q1 2026 2.03M $8.95M Add
Q2 2026 2.01M $6.41M Reduce
Q3 2026 2.47M $7.21M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NAGE and 13F data

NAGE (NIAGEN BIOSCIENCE INC) is a Health Care company. 22 other funds we track also report a position in NAGE. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NAGE

No other tracked fund reports a position in NAGE.

All NAGE fund holders →

FAQ

How long has Tieton Capital Management, LLC held NAGE?

Tieton Capital Management, LLC has disclosed NAGE holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Tieton Capital Management, LLC's current position in NAGE?

As of Q3 2026, Tieton Capital Management, LLC holds 2.47M shares of NAGE (NIAGEN BIOSCIENCE INC), valued at $7.21M, representing 2.15% of its reported portfolio and ranking #24.

Has Tieton Capital Management, LLC been buying or selling NAGE?

In the latest 13F filing (Q3 2026), Tieton Capital Management, LLC increased its position in NAGE. The position peaked in Q2 2025 at 1.58M shares.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.